Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR Study
Clinical trial NCT04197713 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04197713
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2023-02-22
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.